4//SEC Filing
Mills Roger 4
Accession 0001415889-13-000635
CIK 0001070494other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:08 PM ET
Size
5.4 KB
Accession
0001415889-13-000635
Insider Transaction Report
Form 4
Mills Roger
Executive VP, Development
Transactions
- Sale
Common Stock
2013-04-01$7.69/sh−58,584$450,365→ 14,017 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.59 to $7.90 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]All shares reflected in the this filing, including the shares sold and the remaining 14,017 shares, were acquired by Dr. Mills under the ACADIA Pharmaceuticals Employee Stock Purchase Plan.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001368190
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:08 PM ET
- Size
- 5.4 KB